JENNIFER TAINSH: Open Payments
NPI 1891304853 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 13 payments from 8 companies in 2025. Trend: 2023 $5,767 · 2024 $51 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $143 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| BridgeBio Pharma, Inc. | 2 | $52 |
| PFIZER INC. | 2 | $48 |
| Alnylam Pharmaceuticals Inc. | 1 | $39 |
| AtriCure, Inc. | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $20 |
Products named: CAMZYOS, WAINUA, Attruby, VYNDAQEL, ATRICLIP LAA EXCLUSION SYSTEM, JARDIANCE, Wegovy.
Industry payments across CT — which companies pay providers there.
